T. Rowe Price Associates’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.95M | Sell |
2,875,936
-601,855
| -17% | -$2.08M | ﹤0.01% | 1115 |
|
|
2025
Q1 | $9.11M | Buy |
3,477,791
+156,050
| +5% | +$409K | ﹤0.01% | 1132 |
|
|
2024
Q4 | $13.7M | Sell |
3,321,741
-1,958,550
| -37% | -$8.07M | ﹤0.01% | 1071 |
|
|
2024
Q3 | $37.4M | Buy |
5,280,291
+241,276
| +5% | +$1.71M | ﹤0.01% | 830 |
|
|
2024
Q2 | $32.9M | Sell |
5,039,015
-1,840,582
| -27% | -$12M | ﹤0.01% | 836 |
|
|
2024
Q1 | $57.1M | Sell |
6,879,597
-1,701,570
| -20% | -$14.1M | 0.01% | 694 |
|
|
2023
Q4 | $94.5M | Sell |
8,581,167
-27,779
| -0.3% | -$306K | 0.01% | 559 |
|
|
2023
Q3 | $72.4M | Buy |
8,608,946
+263,429
| +3% | +$2.22M | 0.01% | 574 |
|
|
2023
Q2 | $105M | Buy |
8,345,517
+1,482,557
| +22% | +$18.6M | 0.01% | 512 |
|
|
2023
Q1 | $113M | Buy |
6,862,960
+2,369,956
| +53% | +$39M | 0.02% | 487 |
|
|
2022
Q4 | $67.1M | Sell |
4,493,004
-68,359
| -1% | -$1.02M | 0.01% | 584 |
|
|
2022
Q3 | $102M | Sell |
4,561,363
-738,944
| -14% | -$16.5M | 0.02% | 484 |
|
|
2022
Q2 | $88.8M | Buy |
5,300,307
+300,589
| +6% | +$5.03M | 0.01% | 698 |
|
|
2022
Q1 | $150M | Buy |
4,999,718
+844,377
| +20% | +$25.3M | 0.02% | 615 |
|
|
2021
Q4 | $128M | Buy |
4,155,341
+2,537,388
| +157% | +$77.9M | 0.01% | 694 |
|
|
2021
Q3 | $51M | Buy |
1,617,953
+444,471
| +38% | +$14M | ﹤0.01% | 1003 |
|
|
2021
Q2 | $42.9M | Sell |
1,173,482
-331,610
| -22% | -$12.1M | ﹤0.01% | 1082 |
|
|
2021
Q1 | $52M | Buy |
1,505,092
+731,517
| +95% | +$25.3M | 0.01% | 987 |
|
|
2020
Q4 | $32.2M | Sell |
773,575
-13,927
| -2% | -$579K | ﹤0.01% | 1090 |
|
|
2020
Q3 | $33.5M | Buy |
+787,502
| New | +$33.5M | ﹤0.01% | 1002 |
|